Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This is a single center 2-phase study to assess effects of using text messages on adherence to oral chemotherapy for patients with acute lymphoblastic leukemia (ALL) or T-cell lymphoblastic lymphoma.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 15 lat lub więcej w momencie zgłoszenia do badania
- •Diagnoza białaczki limfoblastycznej ostnej (ALL) lub chłoniaka limfoblastycznego typu T
- •Aktualnie otrzymujesz leczenie lękami doustymi (mercaptopuryna i metotreksat) w fazie podtrzymującej
✗ Disqualifies
- •Pacjent lub opiekun nie posiada telefonu zdolnego do odbierania wiadomości tekstowych
- •Pacjent nie wyraża zgody na uczestnictwo w badaniu
Simplified criteria — AI translation
Trial details
- Minimum age
- 15 Years
- Last updated (source)
- July 10, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
University of Chicago Medicine Comprehensive Cancer Center
Chicago, United States
Trial contact
Clinical Trials Intake
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/11/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.